The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
Article in Nature Communications (February 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
Article in Experimental & Molecular Medicine (July 2023)
JARID2 and EZH2, the eminent epigenetic drivers in human cancer
Article in Gene (June 2023)